Ovarian Cancer Statistics. How Common is Ovarian Cancer. American Cancer Society https://www.cancer.org/cancer/types/ovarian-cancer/about/key-statistics.html (2026).
Schepisi, G. et al. Immunotherapy and its development for gynecological (ovarian, endometrial and cervical) tumors: from immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy. Cancers 13, 4318 (2021).
Kurnit, K. C., Fleming, G. F. & Lengyel, E. Updates and new options in advanced epithelial ovarian cancer treatment. Obstet. Gynecol. 137, 108 (2021).
Zhang, X. W., Wu, Y. S., Xu, T. M. & Cui, M. H. CAR-T cells in the treatment of ovarian cancer: a promising cell therapy. Biomolecules 13, 465 (2023).
Rickard, B. P. et al. Malignant ascites in ovarian cancer: cellular, acellular, and biophysical determinants of molecular characteristics and therapy response. Cancers 13, 4318 (2021).
Shender, V. O. et al. Proteome–metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication. Mol. Cell. Proteomics 13, 3558–3571 (2014).
Zhao, G., Cardenas, H. & Matei, D. Ovarian cancer—why lipids matter. Cancers 11, 1870 (2019).
Nieman, K. M. et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17, 1498–1503 (2011).
Prendeville, H. & Lynch, L. Diet, lipids, and antitumor immunity. Cell. Mol. Immunol. 19, 432–444 (2022).
Mukherjee, A. et al. Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance. Cancer Res. 80, 1748–1761 (2020).
Ladanyi, A. et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene 37, 2285–2301 (2018).
Chen, R. R. et al. Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells. Commun. Biol. 2, 281 (2019).
Cubillos-Ruiz, J. R. et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell 161, 1527–1538 (2015).
Jiang, L., Fang, X., Wang, H., Li, D. & Wang, X. Ovarian cancer-intrinsic fatty acid synthase prevents anti-tumor immunity by disrupting tumor-infiltrating dendritic cells. Front. Immunol. 9, 2927 (2018).
Kleinfeld, A. M. & Okada, C. Free fatty acid release from human breast cancer tissue inhibits cytotoxic T-lymphocyte-mediated killing. J. Lipid Res. 46, 1983–1990 (2005).
Howie, D. et al. Foxp3 drives oxidative phosphorylation and protection from lipotoxicity. JCI Insight 2, e89160 (2017).
Anel, A., Richieri, G. V. & Kleinfeld, A. M. Membrane partition of fatty acids and inhibition of T cell function. Biochemistry 32, 530–536 (1993).
Henique, C. et al. Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitate-induced apoptosis. J. Biol. Chem. 285, 36818–36827 (2010).
Manzo, T. et al. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells. J. Exp. Med. 217, e20191920 (2020).
Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity 54, 1561–1577 (2021).
Ma, X. et al. CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metab. 33, 1001–1012 (2021).
Gharpure, K. M. et al. FABP4 as a key determinant of metastatic potential of ovarian cancer. Nat. Commun. 9, 2923 (2018).
Pascual, G. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541, 41–45 (2016).
Simpson-Abelson, M. R. et al. Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells. Cancer Immun. 13, 14 (2013).
Kelleher, R. et al. Extracellular vesicles present in human ovarian tumor microenvironments induce a phosphatidylserine-dependent arrest in the T-cell signaling cascade. Cancer Immunol. Res. 3, 1269–1278 (2015).
Song, M. et al. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature 562, 423 (2018).
Bhatta, M. et al. Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments. J. Immunother. Cancer 9, 3148 (2021).
Shenoy, G. N. et al. Exosomes associated with human ovarian tumors harbor a reversible checkpoint of T-cell responses. Cancer Immunol. Res. 6, 236–247 (2018).
Czystowska-Kuzmicz, M. et al. Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. Nat. Commun. 10, 3000 (2019).
Buck, M. D., O’Sullivan, D. & Pearce, E. L. T cell metabolism drives immunity. J. Exp. Med. 212, 1345–1360 (2015).
Reinfeld, B. I. et al. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature 593, 282–288 (2021).
Reilly, N. A., Lutgens, E., Kuiper, J., Heijmans, B. T. & Wouter Jukema, J. Effects of fatty acids on T cell function: role in atherosclerosis. Nat. Rev. Cardiol. 18, 824–837 (2021).
Listenberger, L. L. et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl Acad. Sci. USA 100, 3077 (2003).
Corvigno, S. et al. In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy. npj Precis. Onc. 7, 115 (2023).
Lillemeier, B. F. et al. TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation. Nat. Immunol. 11, 90–96 (2009).
Zhang, H., Cordoba, S. P., Dushek, O. & Van Der Merwe, P. A. Basic residues in the T-cell receptor ζ cytoplasmic domain mediate membrane association and modulate signaling. Proc. Natl Acad. Sci. USA 108, 19323–19328 (2011).
Xu, C. et al. Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosine-based motif. Cell 135, 702–713 (2008).
Kallikourdis, M. et al. Phosphatidylinositol 4-phosphate 5-kinase β controls recruitment of lipid rafts into the immunological synapse. J. Immunol. 196, 1955–1963 (2016).
Tavano, R. et al. CD28 and lipid rafts coordinate recruitment of Lck to the immunological synapse of human T lymphocytes. J. Immunol. 173, 5392–5397 (2004).
Owen, D. M. et al. High plasma membrane lipid order imaged at the immunological synapse periphery in live T cells. Mol. Membr. Biol. 27, 178–189 (2010).
Gaus, K., Chklovskaia, E., Fazekas De St. Groth, B., Jessup, W. & Harder, T. Condensation of the plasma membrane at the site of T lymphocyte activation. J. Cell Biol. 171, 121–131 (2005).
Dinic, J., Riehl, A., Adler, J. & Parmryd, I. The T cell receptor resides in ordered plasma membrane nanodomains that aggregate upon patching of the receptor. Sci. Rep. 5, 10082 (2015).
Ali, O. & Szabó, A. Review of eukaryote cellular membrane lipid composition, with special attention to the fatty acids. Int. J. Mol. Sci. 24, 15693 (2023).
Arouri, A. & Mouritsen, O. G. Membrane-perturbing effect of fatty acids and lysolipids. Prog. Lipid Res. 52, 130–140 (2013).
Wang, F., Beck-García, K., Zorzin, C., Schamel, W. W. A. & Davis, M. M. Inhibition of T cell receptor signaling by cholesterol sulfate, a naturally occurring derivative of membrane cholesterol. Nat. Immunol. 17, 844–850 (2016).
Yang, W. et al. Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism. Nature 531, 651–655 (2016).
Fan, Y. Y. et al. Remodelling of primary human CD4+ T cell plasma membrane order by n-3 PUFA. Br. J. Nutr. 119, 163 (2018).
Fan, Y.-Y., Ly, L. H., Barhoumi, R., McMurray, D. N. & Chapkin, R. S. Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production. J. Immunol. 173, 6151–6160 (2004).
Zech, T. et al. Accumulation of raft lipids in T-cell plasma membrane domains engaged in TCR signalling. EMBO J. 28, 466 (2009).
Zeyda, M., Staffler, G., Hořejší, V., Waldhäusl, W. & Stulnig, T. M. LAT displacement from lipid rafts as a molecular mechanism for the inhibition of T cell signaling by polyunsaturated fatty acids. J. Biol. Chem. 277, 28418–28423 (2002).
Wang, Y. et al. Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function. Nat. Cell Biol. 27, 835–846 (2025).
Slattery, K. et al. Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer. Sci. Immunol. 10, 4795 (2025).
Meehan, S. D., Hayter, C. & Bhattacharya, S. K. C-Laurdan: membrane order visualization of HEK293t cells by confocal microscopy. Methods Mol. Biol. 2625, 353–364 (2023).
Miguel, L. et al. Primary human CD4+ T cells have diverse levels of membrane lipid order that correlate with their function. J. Immunol. 186, 3505–3516 (2011).
Lei, K. et al. Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy. Nat. Biomed. Eng. 5, 1411–1425 (2021).
Compeer, E. B. et al. A mobile endocytic network connects clathrin-independent receptor endocytosis to recycling and promotes T cell activation. Nat. Commun. 9, 1597 (2018).
Lou, J., Rossy, J., Deng, Q., Pageon, S. V. & Gaus, K. New insights into how trafficking regulates T cell receptor signaling. Front. Cell Dev. Biol. 4, 205569 (2016).
Das, V. et al. Activation-induced polarized recycling targets T cell antigen receptors to the immunological synapse: involvement of SNARE complexes. Immunity 20, 577–588 (2004).
Mestas, J. & Hughes, C. C. W. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731–2738 (2004).
Glatz, J. F. C. & Luiken, J. J. F. P. Time for a détente in the war on the mechanism of cellular fatty acid uptake. J. Lipid Res. 61, 1300–1303 (2020).
Li, Z. et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 3, 321–331 (2006).
Levental, K. R. et al. w-3 polyunsaturated fatty acids direct differentiation of the membrane phenotype in mesenchymal stem cells to potentiate osteogenesis. Sci. Adv. 3, eaao1193 (2017).
Mailer, R. K. W., Gisterå, A., Polyzos, K. A., Ketelhuth, D. F. J. & Hansson, G. K. Hypercholesterolemia enhances T cell receptor signaling and increases the regulatory T cell population. Sci. Rep. 7, 15655 (2017).
Ma, X. et al. Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment. Cell Metab. 30, 143–156 (2019).
Yan, C. et al. Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity. Cancer Cell 41, 1276–1293 (2023).
Fu, G. et al. Metabolic control of TFH cells and humoral immunity by phosphatidylethanolamine. Nature 595, 724–729 (2021).
Redpath, G. M. I. et al. Flotillins promote T cell receptor sorting through a fast Rab5–Rab11 endocytic recycling axis. Nat. Commun. 10, 4392 (2019).
Ghassemi, S. et al. Reducing ex vivo culture improves the antileukemic activity of chimeric antigen receptor (CAR) T cells. Cancer Immunol. Res. 6, 1100–1109 (2018).
Svoboda, J. et al. Enhanced CAR T-Cell therapy for lymphoma after previous failure. N. Engl. J. Med. 392, 1824–1835 (2025).
Ringel, A. E. et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell 183, 1848–1866 (2020).
Williamson, D. GPcalc. GitHub https://github.com/quokka79/GPcalc.git (2017).
Xia, J., Psychogios, N., Young, N. & Wishart, D. S. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 37, W652–W660 (2009).
Sud, M. et al. Metabolomics Workbench: an international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools. Nucleic Acids Res. 44, D463 (2015).